Your browser doesn't support javascript.
loading
Biodistribution and Dosimetry Results from a Phase 1 Trial of Therapy with the Antibody-Radionuclide Conjugate 177Lu-Lilotomab Satetraxetan.
Blakkisrud, Johan; Holtedahl, Jon Erik; Løndalen, Ayca; Dahle, Jostein; Bach-Gansmo, Tore; Holte, Harald; Nygaard, Stine; Kolstad, Arne; Stokke, Caroline.
Afiliación
  • Blakkisrud J; Department of Diagnostic Physics, Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway, and University of Oslo, Oslo, Norway johbla@ous-hf.no.
  • Holtedahl JE; Department of Diagnostic Physics, Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway, and University of Oslo, Oslo, Norway.
  • Løndalen A; Siemens Healthineers, Oslo, Norway.
  • Dahle J; Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
  • Bach-Gansmo T; Nordic Nanovector ASA, Oslo, Norway.
  • Holte H; Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
  • Nygaard S; Department of Oncology, Radiumhospitalet, Oslo University Hospital, Oslo, Norway; and.
  • Kolstad A; Department of Oncology, Radiumhospitalet, Oslo University Hospital, Oslo, Norway; and.
  • Stokke C; Department of Oncology, Radiumhospitalet, Oslo University Hospital, Oslo, Norway; and.
J Nucl Med ; 59(4): 704-710, 2018 04.
Article en En | MEDLINE | ID: mdl-28848035

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunoconjugados / Anticuerpos Monoclonales Tipo de estudio: Etiology_studies Límite: Female / Humans / Male Idioma: En Revista: J Nucl Med Año: 2018 Tipo del documento: Article País de afiliación: Noruega

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunoconjugados / Anticuerpos Monoclonales Tipo de estudio: Etiology_studies Límite: Female / Humans / Male Idioma: En Revista: J Nucl Med Año: 2018 Tipo del documento: Article País de afiliación: Noruega